Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (1982)	3/10/1999 10:03:00 AM
From: rkrw	Read Replies (1) of 10280

<ICE Prozac will not block the introduction of generics-in fact Mylan is set to introduce the first upon patent expire.> Correction. I should have said Barr Labs and actually a handful of generic companies are disputing the LLY Prozac patents and each would be free to market as soon as the Prozac racemate patents expire. If any (albeit unlikely) overturn the patents in court, they'd have a 6 month exclusivity. Its going to be a stampede as soon as the patents expire and prices will follow suit. I don't think anyone is going to make much money on a generic prozac, whether ICE prozac lies in lilly's hands or not, its just the nature of easy to copy generics.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next